Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hanmin Li
Hubei traditional Chinese medicine hospital
Principal Investigator - Jianchun Guo
Hangzhou Xixi hospital
Principal Investigator - Jiefei Wang
Shanghai Public Health Clinical Center
Principal Investigator - Jinmo Tang
Xiamen Hospital of Traditional Chinese Medicine
Principal Investigator - Kewei Sun
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Principal Investigator - Lin Wang
Chengdu Public Health Clinical Center
Principal Investigator - Man Gong, Doctor
Beijing 302 Hospital
Study Chair - Shuqin Zhang
Jilin hematology hospital
Principal Investigator - Wukui Cao
Tianjin Second People's Hospital
Principal Investigator - Xianbo Wang
Beijing Ditan Hospital
Principal Investigator - Xiaozhou Zhou
Affiliated Hospital of Nanjing University of Chinese Medicine
Principal Investigator - Xiuhui Li
Beijing YouAn Hospital
Principal Investigator - Ye Gu
Shenyang Sixth People's Hospital
Principal Investigator - Yunhui Zhuo
Shuguang Hospital of Shanghai University of Traditional Chinese Medicine
Principal Investigator - Zhengang Zhang
Tongji Hospital
Principal Investigator - Zhengfang Liu
Fuzhou Infectious Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- 302 Military Hospital of China
Beijing, Beijing Municipality, China
- Beijing Ditan Hospital
Beijing, Beijing Municipality, China
- Beijing Youan Hospital
Beijing, Beijing Municipality, China
- Fuzhou Infectious Hospital
Fuzhou, Fujian, China
- Xiamen Hospital of Traditional Chinese Medicine
Xiamen, Fujian, China
- Hubei Hospital of Traditional Chinese Medicine
Wuhan, Hubei, China
- Tongji Hospital, Huazhong University of Science and Technology
Wuhan, Hubei, China
- the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Changsha, Hunan, China
- Jilin Hepatology Hospital
Changchun, Jilin, China
- the Sixth People'S Hospital of Shenyang
Shenyang, Liaoning, China
- Shanghai Public Health Clinical Center
Shanghai, Shanghai Municipality, China
- Shuguang Hospital, Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, China
- Chengdu Public Health Clinical Center
Chengdu, Sichuan, China
- the Second People'S Hospital of Tianjin
Tianjin, Tianjin Municipality, China
- Hangzhou Xixi Hospital
Hangzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Jan 2019
- Primary completion
- 30 Jun 2021
- Completion
- 30 Jun 2021
- Last update posted
- 31 Mar 2022
- Registered enrollment
- 516
- Registry id
- NCT03577938
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.